Teleflex Incorporated (NYSE:TFX) Given Average Rating of “Reduce” by Brokerages

Teleflex Incorporated (NYSE:TFX) has been given a consensus rating of “Reduce” by the twelve ratings firms that are covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $142.4286.

Several brokerages have weighed in on TFX. Wall Street Zen lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Truist Financial boosted their price target on Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research note on Thursday, December 18th. Zacks Research downgraded Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a $135.00 target price on shares of Teleflex in a report on Wednesday, December 17th.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of TFX. MassMutual Private Wealth & Trust FSB increased its position in Teleflex by 57.9% during the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock worth $26,000 after buying an additional 77 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. boosted its stake in shares of Teleflex by 242.9% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock valued at $26,000 after acquiring an additional 153 shares during the last quarter. Hantz Financial Services Inc. increased its position in Teleflex by 248.8% during the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after purchasing an additional 199 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Teleflex during the 3rd quarter worth about $35,000. Finally, Quent Capital LLC acquired a new position in Teleflex in the 3rd quarter valued at about $38,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Trading Up 0.4%

NYSE:TFX opened at $122.49 on Friday. Teleflex has a 1 year low of $102.58 and a 1 year high of $185.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. The stock has a fifty day moving average price of $119.09 and a two-hundred day moving average price of $121.07. The stock has a market capitalization of $5.41 billion, a price-to-earnings ratio of -16.67, a PEG ratio of 1.36 and a beta of 0.93.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, topping analysts’ consensus estimates of $3.38 by $0.29. The business had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The business’s revenue for the quarter was up 19.4% on a year-over-year basis. During the same period in the prior year, the company posted $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, sell-side analysts anticipate that Teleflex will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were given a $0.34 dividend. The ex-dividend date was Friday, November 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. Teleflex’s dividend payout ratio is currently -18.50%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.